NSE - Delayed Quote INR

Dr. Lal PathLabs Limited (LALPATHLAB.NS)

2,704.00

+36.25

+(1.36%)

At close: April 11 at 3:30:01 PM GMT+5:30

Dr. Lal PathLabs Ltd (BOM:539524) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ...

Dr. Lal PathLabs Ltd (BOM:539524) reports a 10.7% revenue increase and outlines strategic expansion into underserved markets.

GuruFocus.com 2 months ago

LALPATHLAB.NS
+1.36%
Dr. Lal PathLabs Ltd (BOM:539524) Q2 2025 Earnings Call Highlights: Strong Revenue and Profit ...

Dr. Lal PathLabs Ltd (BOM:539524) reports robust financial performance with significant growth in revenue and profit, while focusing on expanding its service network and investing in technology.

GuruFocus.com 5 months ago

LALPATHLAB.NS
+1.36%
India's Dr Lal Path Labs posts bigger-than-expected Q2 profit on demand for medical tests

The company's consolidated net profit increased 18% year-over-year to 1.29 billion rupees ($15.4 million), increasing for the sixth quarter in a row. The company, which operates about 300 labs in India, said the number of samples it tested climbed 10% and that it is building back volumes. Analysts said awareness regarding health and wellness is rising in the country and, along with Dr. Lal PathLabs' expansion into smaller cities, is boosting demand for medical tests.

Reuters 5 months ago

LALPATHLAB.NS
+1.36%

Performance Overview

Return	LALPATHLAB.NS	S&P BSE SENSEX (^BSESN)
YTD	-9.69%	-3.82%
1-Year	+18.29%	+0.16%
3-Year	+0.18%	+27.46%

Try again.